Institutional members access full text with Ovid®

Share this article on:

Update on revascularization in patients with heart failure and coronary artery disease

Hage, Fadia; Hage, Alib; Haddad, Haissamc; Kiaii, Bobb

Current Opinion in Cardiology: March 2018 - Volume 33 - Issue 2 - p 232–236
doi: 10.1097/HCO.0000000000000483
HEART FAILURE: Edited by Haissam Haddad

Purpose of review The review explores the recent findings surrounding the evaluation and the treatment of patients with heart failure and coronary artery disease. It also shed the light on the gaps in this area.

Recent findings Surgical revascularization in patients with ischemic cardiomyopathy has the potential to offer symptomatic and survival benefits.

Summary Patients with heart failure and coronary artery disease should be considered candidates for revascularization on the basis of their symptoms, extent of the disease, and comorbidities. Surgical revascularization in these patients provides a symptomatic relief, and a survival benefit.

aFaculty of Medicine, University of Ottawa, Ottawa

bDepartment of Cardiac Surgery, London Health Sciences Centre, London, Ontario

cDepartment of Medicine, University of Saskatchewan, Saskatoon Health Region, Saskatoon, Saskatchewan, Canada

Correspondence to Bob Kiaii, MD, FRCSC, Department of Cardiac Surgery, London Health Sciences Centre, 339 Windermere Road, London, Ontario, N6A 5A5, Canada. Tel: +1 519 685 8500 ext. 33153; e-mail: Bob.Kiaii@lhsc.on.ca

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.